Elif Sertesen Camoz
Overview
Explore the profile of Elif Sertesen Camoz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
2
Citations
1
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bolek H, Kuzu O, Camoz E, Sim S, Sekmek S, Karakas H, et al.
Cancer Commun (Lond)
. 2025 Feb;
PMID: 39927571
No abstract available.
2.
Onur I, Akdur P, Firat H, Camoz E, Ciledag N, Savran B, et al.
Support Care Cancer
. 2025 Feb;
33(3):167.
PMID: 39921759
Aim: The aim of our study is to evaluate the relationship between sarcopenia, overall survival (OS), and chemotherapy toxicity in patients with unresectable/metastatic soft tissue sarcoma (STS) treated with adriamycin...
3.
Bolek H, Kuzu O, Camoz E, Sim S, Sekmek S, Karakas H, et al.
Clin Transl Oncol
. 2025 Jan;
PMID: 39812937
Purpose: Identifying prognostic indicators for risk stratification in metastatic renal cell carcinoma (mRCC) is crucial for optimizing treatment strategies and follow-up plans. This study aims to investigate the prognostic role...
4.
Onur I, Akdur P, Camoz E, Ciledag N, Yildiz F
Future Oncol
. 2024 Oct;
20(38):3133-3140.
PMID: 39378049
To evaluate the relationship between liver metastasis volume and survival in colorectal cancer patients using the volumetric measurement method. 114 colorectal cancer patients with isolated liver metastases were included in...
5.
Onur I, Firat H, Camoz E, Yildiz F
Cureus
. 2024 Aug;
16(7):e65003.
PMID: 39161499
Gallbladder and biliary tract tumors are rare but highly fatal cancers. In patients diagnosed with unresectable/metastatic gallbladder cancer and cholangiocarcinomas, systemic chemotherapy is recommended if the patient's performance is good....